載入...
Tetrabenazine in the treatment of Huntington’s disease
Tetrabenazine (TBZ), a catecholamine-depleting agent initially developed for the treatment of schizophrenia, when tested for other indications, has proven to be more useful for the treatment of a variety of hyperkinetic movement disorders. These disorders include neurological diseases characterized...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2656291/ https://ncbi.nlm.nih.gov/pubmed/19381278 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|